ToolGen Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:ToolGen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011849
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ToolGen Inc (ToolGen) is a genome editing company that concentrates on translating the genetic knowledge into transformative products for biomedicine and agriculture. The company creates intellectual property rights for essential tools and technologies for editing the genetic information in plant, microbial, animal, and human cells. It offers CRISPR/ CAS9 services; engineering services and reporter services. ToolGen offers RNA-guided endonucleases, an engineered nuclease based on a bacterial CRISPR/Cas9 system that provides novel tools for the genome editing. The company has presence in China, South Korea and the US. ToolGen is headquartered in Seoul, South Korea.

ToolGen Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ToolGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
ToolGen Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
ToolGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
ToolGen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
ToolGen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
ToolGen Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Green Cross Cell and ToolGen to Enter into Partnership 10
Licensing Agreements 11
Thermo Fisher Enters into Licensing Agreement with ToolGen for CRISPR/Cas9 11
Life Technologies Enters Into Licensing Agreement With ToolGen For TAL Effector Technology 12
ToolGen Inc – Key Competitors 13
ToolGen Inc – Key Employees 14
ToolGen Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
ToolGen Inc, Pharmaceuticals & Healthcare, Key Facts 2
ToolGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
ToolGen Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
ToolGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
ToolGen Inc, Deals By Therapy Area, 2011 to YTD 2017 8
ToolGen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Green Cross Cell and ToolGen to Enter into Partnership 10
Thermo Fisher Enters into Licensing Agreement with ToolGen for CRISPR/Cas9 11
Life Technologies Enters Into Licensing Agreement With ToolGen For TAL Effector Technology 12
ToolGen Inc, Key Competitors 13
ToolGen Inc, Key Employees 14

★海外企業調査レポート[ToolGen Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lophius Biosciences GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Lophius Biosciences GmbH (Lophius) is a biotechnology company that develops and markets T cell-based diagnostic systems and research tools in the areas of transplantation, infectious and autoimmune diseases. The company’s T-track immunoscan assay is a test in natural or induced immune modula …
  • Kawakami Paint Manufacturing Co., Ltd. (4616):企業の財務及び戦略的SWOT分析
    Summary Kawakami Paint Manufacturing Co., Ltd. (Kawakami Paint) is a paint company that manufactures and markets paints and painting related equipment. The company offers products such as anti-corrosive paint, architectural coatings, fireproof material, formaldehyde regulated product, paint for buil …
  • Cellmid Limited (CDY):企業のM&A・提携動向(医療機器分野)
    Summary Cellmid Limited (Cellmid) formerly Medical Therapies Limited is a biotechnology company that develops therapies and diagnostic tests for cancer, inflammation and auto-immune disorders. The company offers products that include midkine ELISA kit, advangen international hair loss products and e …
  • Cepheid (CPHD):製品パイプライン分析2015
    Summary Cepheid is a molecular diagnostic company. It offers tests, reagents, and systems for testing in clinical and non-clinical markets. The company's flagship product, GeneXpert system incorporates sample preparation, nucleic acid extraction and purification, DNA amplification, and detection int …
  • VinaPhone Company :企業の戦略・SWOT・財務分析
    SummaryVinaPhone Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findi …
  • Cedars-Sinai Medical Center-製薬・医療分野:企業M&A・提携分析
    Summary Cedars-Sinai Medical Center (Cedars-Sinai), formerly Kaspare Cohn Hospital is an academic and medical center that provides healthcare services for patients and medical professionals, and research and education services. The center offers treatments for various conditions such as abdominal pa …
  • The Higashi-Nippon Bank, Ltd.:企業の戦略・SWOT・財務情報
    The Higashi-Nippon Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Higashi-Nippon Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Osisko Mining Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Osisko Mining Corporation Merge …
  • North Energy ASA (NORTH):企業の財務及び戦略的SWOT分析
    Summary North Energy ASA (North Energy) is an upstream oil and gas company that carries out exploration and development activities in Norwegian Continental Shelf (NCS). The company’s business include license mapping and drilling programmes. It enhances its production activity and expands its acreage …
  • Qantas Airways Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Qantas Airways Limited Mergers …
  • Tyson Fresh Meats, Inc.:企業の戦略・SWOT・財務分析
    Tyson Fresh Meats, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tyson Fresh Meats, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Boone Electric Cooperative:発電所・企業SWOT分析
    Boone Electric Cooperative - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • IVP Limited (IVP):企業の財務及び戦略的SWOT分析
    Summary IVP Limited (IVP) is a chemical company that manufactures and exports chemicals, castings and allied products. The company’s product categories include industrial chemicals, foundry chemicals, vanaspati and edible oil, and advanced ceramics. Its products comprise phenol base resins, alkyd ba …
  • Echosens SA:企業のM&A・提携動向(医療機器分野)
    Summary Echosens SA (Echosens), a subsidiary of Inner Mongolia Free Han & Mongolia Pharmaceutical Co Ltd is a medical device company that offers diagnostic products. The company designs and develops diagnosis solutions for patients with chronic liver diseases. It offers FibroMeter tests, FibroScan d …
  • TransAmerican Energy Inc.:企業のM&A・提携動向(石油・ガス分野)
    Summary TransAmerican Energy Inc. (TransAmerica) is an oil and gas company that carries out acquisition, exploration and production of oil and natural gas resources. The company provides oil and gas projects at various stages of production and development in both Canada and the US. TransAmerica oper …
  • Alimera Sciences Inc (ALIM):医療機器:M&Aディール及び事業提携情報
    Summary Alimera Sciences Inc (Alimera) is a biopharmaceutical company that researches, develops and commercializes prescription ophthalmic pharmaceuticals. The company’s products include Iluvien, an intravitreal implant of fluocinolone acetonide which is indicated for the treatment of chronic diabet …
  • Saladax Biomedical, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Saladax Biomedical, Inc. (Saladax) is a diagnostic company. The company develops and offers diagnostic tests for the delivery of medicine in oncology. Its products include My5-FU, MyPaclitaxel and MyDocetaxel. Saladax’s My5-FU measures and helps physicians to optimize a patient’s exposure to …
  • Optos Plc (OPTS):企業のM&A・提携動向(医療機器分野)
    Summary Optos plc (Optos) is a medical technology company dealing with manufacture and marketing of retinal imaging devices. It offers ultra wide field and high resolution retinal imaging devices for early detection of ophthalmic conditions like retinal detachment, glaucoma, cataracts, retinal holes …
  • Gammon Infrastructure Projects Limited (GAMMNINFRA):企業のM&A・提携動向(発電分野)
    Summary Gammon Infrastructure Projects Limited (GIPL) is an infrastructure project development company. It undertakes projects on a public private partnership basis (PPP) across various sectors including hydro power, roads and expressways, ports, urban infrastructure, airports, special economic zone …
  • BrainLAB AG:企業のM&A・提携動向(医療機器分野)
    Summary Brainlab AG (Brainlab) is a healthcare information technology (IT) company. It develops, manufactures and markets software driven medical technology solutions. The company provides technology in the areas of radiosurgery and radiotherapy, and surgical fields including neurosurgery, orthopaed …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆